Export controls on COVID-19 rapid antigen kits: licensing required with application window, quota allocation, and documentary eligibility. Export authorization for COVID-19 Rapid Antigen Testing kits is subject to a fixed quota and must be sought online through the DGFT ECOM system within the prescribed application window; export licences, if granted, will be valid for six months and applications will be examined per the Handbook of Procedures. Eligibility requires documentary proof of manufacture, supporting purchase orders or invoices, and a manufacturer's undertaking certifying that domestic commitments have been fulfilled. All documents must be self attested and incomplete or late applications will not be considered.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Export controls on COVID-19 rapid antigen kits: licensing required with application window, quota allocation, and documentary eligibility.
Export authorization for COVID-19 Rapid Antigen Testing kits is subject to a fixed quota and must be sought online through the DGFT ECOM system within the prescribed application window; export licences, if granted, will be valid for six months and applications will be examined per the Handbook of Procedures. Eligibility requires documentary proof of manufacture, supporting purchase orders or invoices, and a manufacturer's undertaking certifying that domestic commitments have been fulfilled. All documents must be self attested and incomplete or late applications will not be considered.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
